According to Demis Hassabis on X, a viral thread by @IterIntellectus describes an Australian technologist who sequenced a rescue dog's tumor for $3,000 and used ChatGPT and AlphaFold to identify mutated proteins, match targets, and design a custom mRNA cancer vaccine, with a professor calling the effort gobsmacking and reporting the tumor halved after the first injection; the account underscores accelerating accessibility of protein structure prediction and AI copilots in translational workflows, though formal ethics approval and clinical standards still govern delivery (as reported by @IterIntellectus via X). For AI businesses, the case highlights demand for end-to-end tooling that connects sequencing data, variant calling, neoantigen prediction, structural modeling, and personalized vaccine design, creating opportunities in regulated LLM agents, validation pipelines, and compliant deployment for oncology and veterinary care, according to the X posts cited.

According to Satya Nadella, Microsoft's AI research team has achieved a significant breakthrough in understanding the complex protein dynamics that drive biological function. Leveraging advanced AI algorithms, the team has developed new methods for modeling and predicting protein movements, which could accelerate drug discovery, enhance disease modeling, and open new business opportunities in biotechnology and pharmaceutical industries. This advancement underscores the increasing role of AI in life sciences, enabling faster insights and more precise therapeutic targets (source: Satya Nadella, Twitter, August 18, 2025).